Jay Bowsher

Jay Bowsher is a pharmaceutical executive currently serving as the VP of Immunology, Global Commercial Development at CSL Behring. Jay has extensive experience in global commercialization strategy, marketing, and sales, having held leadership positions at Pfizer where they directed cross-functional teams and oversaw significant product launches, including responsibilities for the marketing strategy of XTANDI. Jay's previous roles include Vice President of Sales and Marketing for XELJANZ and various leadership positions at Wyeth, where they managed large sales teams and global P&L responsibilities. Academic credentials include a BS in Business Administration from Lander University and an MBA from Capital University.